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Prior endovascular abdominal aortic aneurysm
repair provides no survival benefits when the
aneurysm ruptures
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Robert Y. Rhee, MD,a and Michel S. Makaroun, MD,a Pittsburgh, Pa
Objective: It has been proposed that prior endovascular abdominal aortic aneurysm (AAA) repair (EVAR) confers
protective effects in the setting of ruptured AAA (rAAA). This study was conducted to compare outcomes of rAAA repairs
in patients with and without prior EVAR.
Methods: A retrospective review identified 18 patients with (group 1) and 233 patients without (group 2) antecedent
EVAR who presented with rAAA from January 2001 to December 2008. Patient characteristics and perioperative
variables were noted and the outcomes were compared. Multiple logistic regression was used to identify factors
contributing to morbidity and mortality and Kaplan–Meier analyses to estimate late survival rates.
Results: Baseline characteristics were similar between groups. Mean age was 78 years in group 1 and 74.8 years in group
2 (P  .17). Men comprised 83.3% of patients in group 1 and 77.3% in group 2 (P  .77). Hemodynamic instability at
rAAA was noted with similar frequency between groups, 55.6% vs 52.6%, respectively (P  .99). Mean time from EVAR
to rAAA was 4.0 years and from last follow-up computed tomography (CT) 1.2 years. The devices involved were Ancure
(Guidant, Menlo Park, Calif) (9), AneuRx (Medtronic, Minneapolis, Minn) (5), Zenith (Cook Medical Inc, Blooming-
ton, Ind) (3), and Excluder (W.L Gore, Flagstaff, Ariz) (1). Mean preoperative AAA size was 6.4 cm in group 1. All but
1 patient had an endoleak at the time of rupture. Of 14 patients with CT follow-up, only 3 patients had a known increase
in size (>5 mm) and only 3 were known to have an endoleak. Fifteen patients were treated by a single intervention,
whereas 3 patients underwent multiple procedures. In group 2, open repair was performed in 218 patients and EVAR in
15. Morbidity (66.7% vs 56.7%) and in-hospital mortality (38.9% vs 36.9%) were nearly identical between groups.
One-year survival rates (27.8% vs 48.2%; P .15) were also similar. The mortality rates for EVAR for primary rAAA was
20% as compared to 38.1% for open repair for rAAAs (P  .27).
Conclusion: rAAA remains a lethal problem in patients with and without prior EVAR alike. An existing endograft provides
neither acute nor 1-year survival benefits after rAAA repairs. Prediction of patients at risk for rupture post-EVAR is difficult,
as only a minority of patients had a known prior endoleak or sac enlargement. (J Vasc Surg 2010;52:1127-34.)Although endovascular aneurysm repair (EVAR) has
been proven to be an effective method of treating an
abdominal aortic aneurysm (AAA) with superior short-
term outcome data by both prospective randomized
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has not completely eliminated AAA rupture in long-term
follow-up. Post-EVAR rupture of an AAA occurs from
incomplete exclusion of the aneurysm by a variety of
endoleaks and endotension. The reported incidence of
incomplete exclusion ranges from 6% to 50%.4 Cumula-
tive annual risk of rupture after EVAR depends on a
variety of factors and is estimated to occur between 0.2%
and 1.0% per year.4-7
Some reports of late aneurysm rupture after EVAR
have suggested that a stent graft may confer a survival
benefit compared with de novo rupture due to the higher
likelihood of hemodynamic stability.8,9 The reported
operative mortality rates for repair of post-EVAR rup-
tured abdominal aortic aneurysms (rAAA) have ranged,
however, from 17% to 62%.5,9-11 The purpose of this
study was to identify any predictive factors of late rupture
in patients previously treated by EVAR and to compare
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rupture of untreated AAA.
MATERIALS AND METHODS
A retrospective review of medical records at the
University of Pittsburgh Medical Center (UPMC) iden-
tified 251 consecutive patients who presented with an
rAAA without thoracic extension from January 2001 to
December 2008. A rupture of the aortic neck into the sac
secondary to aggressive balloon dilatation and severe
oversizing of the endograft were excluded. Other acute
conversions for aorto-enteric fistulae (2 patients) were
also excluded. The diagnosis of rupture was made by
review of preoperative computed tomography (CT) find-
ings. This was confirmed by a clear description of blood
outside the aneurysm wall, either in the retroperito-
neum, mesentery, or the peritoneal cavity in those pa-
tients undergoing open repair. The initial rupture epi-
sode was counted as the index procedure. This study was
approved by the Institutional Review Board of the Uni-
versity of Pittsburgh.
Baseline patient characteristics and perioperative variables
were recorded. Preoperative shock was defined as systolic
blood pressure less than 80 mm Hg or a requirement for
preoperative cardiopulmonary resuscitation (CPR). Postoper-
ative renal insufficiency was defined as serum creatinine
greater than 2.0mg/dL.12Operativemortality was defined as
death within 30 days of operation or in-hospital death, if later
than 30 days. Open or endovascular repairs were performed
by 14 different vascular surgeons at UPMC during the study
period.
Quantitative variables are summarized as mean and SD,
and categorical variables as counts and percentages. Base-
line characteristics were compared using t test for quantita-
tive variables or 2 test and Fisher exact test for categorical
variables. Univariate analysis was used to assess demo-
graphic, clinical, procedural, and postoperative factors as-
sociated with operative deaths (Table I). Multiple logistic
regression analysis was performed to identify factors that
were independently associated with operative mortality.
Survival rates were calculated using Kaplan–Meier method,
using the log-rank test for comparison of curves, if appro-
priate. Social Security Death Index was used to supplement
data on late mortality. Analyses were performed with the
statistical software R, version 2.9.2 under the alpha level of
0.05 (http://www.r-project.org).
RESULTS
The baseline characteristics of the patients are detailed
in Table I. A total of 251 patients underwent repair of
rAAAs; 18 patients with (group 1) and 233 patients with-
out (group 2) antecedent EVAR. Mean age was similar
between the two groups, 78.0 years (range, 59-92) in
group 1 and 74.8 years (range, 50-92) in group 2 (P 
.17). Men comprised 83.3% of the patients in group 1 and
77.3% in group 2 (P  .77).
Hemodynamic instability, defined as systolic blood
pressure80mmHg, at presentation occurred in 55.6% ofthe patients in group 1 and in 52.6% in group 2 (P  .99).
Preoperative CPR was performed with similar frequency,
16.7% in group 1 and 22.2% in group 2 (P  .77). The
prevalence of comorbidities was similar between the two
groups except the incidence of coronary artery disease and
current smoking (Table I).
Rupture after a previous EVAR (group 1). Eighteen
patients presented with rAAAwith the following endopros-
theses: Ancure (Guidant, Menlo Park, Calif) (9), AneuRx
(Medtronic, Minneapolis, Minn) (5), Zenith (Cook Med-
ical Inc, Bloomington, Ind) (3), and Excluder (W.L. Gore,
Flagstaff, Ariz) (1). Indications for original EVAR was for
AAA for all except 1 patient (patient #18) who was treated
for an isolated right common iliac artery aneurysm with an
Excluder iliac limb. Five patients had undergone the initial
Table I. Baseline characteristics and demographics
comparison of ruptured abdominal aortic aneurysm
(rAAA) patients with and without antecedent
endovascular aneurysm repair (EVAR)
Variable







Age (years) 78 74.8 .17
Male 83.3 77.3 .77
History of HTN 77.8 79 .99
History of COPD 33.3 32.3 .99
History of CAD 72.2 54.5 .22
History of DM 22.2 15.3 .50
History of PVD 33.3 21.3 .24
History of CVA 5.6 14.5 .48
History of CRF 22.2 14.9 .49
History of HD 0 .5 .99
Current smoking 11.1 34.4 .06
Preoperative characteristics
Preoperative SBP 80 mm
Hg 55.6 52.6 .99
Preoperative CPR 16.7 22.2 .77
Blood chemistry
Mean hemoglobin (g/dL) 9.9 11.1 .007
Mean platelet 186 213 .27
Intraoperative variables
RBC transfusion in units 3.26 7.14 .001
FFP transfusion in units 1.6 4.26 .001
Platelet transfusion in
packs 0.4 1.04 .003
Postoperative complications
In-hospital death 38.9 36.9 .99
Renal failure requiring HD 26.7 23.9 .76
Myocardial infarction 50 38.3 .43
Tracheostomy 31.2 23.8 .55
Stroke 0 8.8 .62
Intestinal ischemia 18.8 19.8 .99
Data are % (n) or mean  SD.
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary dis-
ease;CPR, cardiopulmonary resuscitation;CRF, chronic renal failure;CVA,
cerebrovascular accident; DM, diabetes mellitus; FFP, fresh frozen plasma;
HD, hemodialysis; HTN, hypertension; PVD, peripheral vascular disease;
RBC, red blood cell; SBP, systolic blood pressure.EVAR at an outlying hospital.
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years (range,0.3-7.8) after EVAR (Table II). There were
two ruptures within the first year and five within the first 3
years. It should be noted that 1 patient presented with a
rupture even after partial endograft explantation. This was a
91-year-old man (patient #1) who underwent an elective
EVAR with a Zenith device at age 90. He had type I and
type II endoleaks with sac expansion despite two interven-
tions consisting of proximal Palmaz stent (Cordis Endovas-
cular, Warren, NJ) placement and inferior mesenteric artery
(IMA) coil embolization, and underwent partial endograft
explantation (with the iliac limbs left behind) at 14 months
post-EVAR. He recovered from that operation well, but
the AAA ruptured 20 months later from distal bilateral type
I endoleaks.
All but 1 patient with an rAAA had an endoleak that
was confirmed by CT scan or operative findings at the time
of the rupture. Isolated type Ia (proximal) endoleaks were
noted in 9 patients (of which 2 were associated with migra-
tion), type Ib (distal) in 5 patients, and type III in 3
patients. Multiple endoleaks were seen in 3 patients (Ib and
Table II. Detailed description of patients with ruptured
abdominal aortic aneurysms (rAAA) with antecedent






Interval from initial EVAR to rAAA 4.0 years
Interval from last follow-up to rAAA 1.2 years
Patients with 2 years since last follow-
up to rAAA 3
Patients with rAAA within 1 year of last
follow-up 10
Patients with secondary interventions before
rAAA 4
Aneurysm characteristics during follow-up
Mean size at initial EVAR, mm 63.5
Endoleak at last follow-up, (n  13)
None 10 (77%)
Type Ia 1 (8%)
Type II 2 (15%)
Unknown (no contrast on CT)
Sac size at last follow-up (n  13)
Increase in sac size 3 (23%)
Decrease in sac size 6 (46%)
No change in sac size 4 (31%)
Aneurysm characteristic at the time of
rupture
Mean size at rupture, mm 67.6
Endoleak at rAAA, (n  18)
Type I proximal 9 (50%)
Type I distal 6 (33%)
Type II 2 (10%)
Type III fabric fatigue 2 (10%)
Type III modular disconnection 1 (5%)
Undetermined 1 (5%)
AAA, Abdominal aortic aneurysm; CT, computed tomography; EVAR,
endovascular aneurysm repair; rAAA, ruptured abdominal aortic aneurysm.II, Ia and III, and Ib, II, and III in 1 patient each). In 1patient the endoleak was undetermined. Two patients with
proximal migration presented with rupture. The first one
occurred 10 months after the successful index EVAR with
normal baseline CT scan, whereas the second aneurysm
ruptured 7.8 years after EVAR. The last CT scan without
contrast enhancement obtained 1.7 years before rupture
had shown a stable sac size with 10 mm distal migration.
This was neither treated nor followed further. Most of the
endoleaks at the time of rupture were previously undiag-
nosed on the last imaging follow-up.
Follow-up CT scans after initial EVARwere available in
14 patients, with contrast enhancement in 11; 3 of the 14
were baseline studies 1 month postoperatively. In 1 patient
who had the index EVAR performed at an outlying hospi-
tal, the follow-up information was not available. The mean
interval from last follow-up imaging to rupture was 1.2 
1.1 years (range, 2 days to 3.9 years). Last follow-up
before rupture was within a year in 9 patients, between 1
and 2 years in 5 patients, and more than 2 years in only 3
patients.
Endoleak data were available at last follow-up in 13
patients (Table II). An endoleak had been present in only 5
patients (38%). A type II endoleak was noted in 2 patients,
both of which were associated with an enlarging sac, in-
cluding 1 patient who had an endograft infection. In 1
patient, a type I endoleak was noted with increasing sac
size. This patient’s aneurysm ruptured 2 days later while he
was in the hospital undergoing preparation for further
evaluation and treatment. In 3 additional patients, the
status of the endoleak could not be ascertained due to the
CT scans without contrast enhancement; these were asso-
ciated with sac growth, shrinkage, and stability in 1 patient
each.
Mean preoperative aneurysm size was relatively large,
6.4 1.3 cm in the patients with later rupture after EVAR.
AAA sac size analysis was limited to 13 patients who had at
least one follow-up imaging beyond the 1-month postop-
erative study and only 3 patients had a known sac enlarge-
ment of more than 5 mm. Sac behavior at last follow-up is
detailed in Tables II and III.
Secondary endovascular interventions had been per-
formed in 4 patients before rupture. One patient had
undergone partial removal of the stent graft as mentioned
above. Two patients had coil embolization of branch vessels
and 1 patient required an iliac limb extension.
A total of 23 open/endovascular interventions were
performed (Table III). Multiple interventions were under-
taken in 3 patients. One patient (patient #1, mentioned
above) initially underwent a left iliac limb extension for
rupture due to a left type Ib endoleak. However, he con-
tinued to bleed requiring multiple units of blood product
transfusion over the ensuing 6 days. He then underwent
right iliac limb extension. Although he stopped bleeding,
he never recovered, and he died in the hospital. One patient
(patient #3) underwent bilateral iliac limb extension when
he presented with an rAAA. This was unsuccessful and
required ligation of the right hypogastric artery via a retro-
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aneurysms (rAAA)
Pt # Gender Age Endograft type
Interval from EVAR
to rAAA (years)
Interval from last F/U
to rAAA (years)
1a M 91 Zenith 2.8b 1.7b
2 M 77 AneuRx 3.3 3.2
3a M 71 Ancure 2.4 0.4
4c F 74 AneuRx 3.3 1.0
5 F 77 Zenith 0.8 0.7
6 M 73 AneuRx 5.7 1.5
7c F 73 Ancure 0.5 0.1
8 M 85 Ancure tube 4.9 3.9
9 M 82 AneuRx 7.8 1.7
0c M 87 AneuRx 5.8 0.7
1 M 82 Ancure 3.7 2.7
2 M 68 Ancure 4.6 2 days
3 M 59 Ancure 2.6 0.6
4c M 78 Ancure N/A N/A
5 M 92 Ancuree 5.3 0.4
6a,f M 64 Ancure 6 0.1
7c M 89 Zenith 3.4 0.6
8 M 83 Excluder iliac 4.8 1.3
Pt # Cause of rupture
1a Bilateral type Ib
2 Unknown (ct not done)
3a 1: Type Ib, bilateral
2: Type II (from right IIA)
3: Type Ib
4c Proximal collapse with type Ia
5 Type Ia (migration)
6 Type III (left limb disconnection)
7c Type Ia (graft infection with MRSA)
8 Type III (a hole in midbody)
9 Type Ia (migration)
10c Type Ib, left










AAA,Abdominal aortic aneurysm;CT, computed tomography; EIA, external iliac artery; embo, embolization; EVAR, endovascular aneurysm repair; F, female;
F/U, follow-up; IIA, internal iliac artery; IMA, inferior mesenteric artery;M,male;MRSA,methicillin-resistant staphylococcus aureus;N/A, not available;Op.,
operative; rAAA, ruptured abdominal aortic aneurysm.
aUnderwent multiple interventions.
bEndograft was explanted and replaced with a surgical graft at 14 months post-EVAR and presented with rupture 20 months later. The time of endograft
explant is considered the last follow-up , although the patient was seen 6 months before rupture without any imaging study. It was considered that there was
no endoleak upon open conversion.
cInitial EVAR performed at outside of University of Pittsburgh Medical Center system.
dDecreased by 5 mm during follow-up but increased back to baseline size on the last follow-up.
eAortouniiliac and cross-femoral bypass.
fThe patient presented with three separate episodes of rAAA.
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 5 Cho et al 1131Table III. Continued
AAA size @ 1 mo
postop (mm)
AAA size @ last
F/U (mm)
AAA size change compared
to baseline @ last F/U Endoleak @ last F/U No. of prior intervention(s) and details
89 N/Ab N/Ab Nob 1: Palmaz stent for type Ia leak
2: IMA coil embo; coil embo for recurrent type
Ia leak
3: Explantation (main body only)
51 N/A N/A No None
57 62 Increased Type II 1: Lumbar artery coil embo
70 46 Decreased No None
61 N/A N/A No None
77 80 No change No 1: Right limb extension @ 2 years
45 50 Increased Type II None
53 44 Decreased No None
60 59 No change No contrast None
60 44 Decreased No contrast None
72 N/A N/A No None
50 37 No changed No None
94 68 Decreased No None
N/A N/A N/A N/A Unknown
55 45 Decreased No None
65 63 No change No 1: IMA and right lumbar coil embo








Details of treatment Outcome
1: Left iliac limb extension
2: Right iliac limb extension
Op. death
Explantation Died @ 4 mos
1: Bilateral iliac Wallgraft placement
2: Ligation of right IIA
3: Interposition grafting of the left limb; ligation of a lumbar artery
Died @ 7 mos
Multiple proximal extender cuff (4, Zenith and Excluder) and Palmaz stent placement Op. death
Proximal extension cuff (Zenith) with Palmaz stent Died @ 8 mos
Left limb extension Alive @ 19 mos
Explanted (a portion of right limb left behind) Died @ 5 mos
Explanted Op. death
Aortic extender: Zenith cuff and 3 Excluder cuffs Op. death
Left iliac limb extension Died @ 14 mos
Explanted Alive @ 72 mos
Right iliac limb extension with a Wallgraft Alive @ 86 mos
Explanted (bilateral limbs left behind) Alive @ 45 mos
Explanted (right limb left behind) Died @ 3 mos
Extended with AneuRx limb and Wallgraft Op. death
1: Left iliac limb extension; coil embolization of the distal landing zone
2: Open ligation of lumbar artery
3: Partial explantation leaving the proximal and iliac limbs behind; bifurcated graft sewn end-side to
bilateral EIA with proximal iliac limbs ligation
Op. death
Endovascular repair attempted but patient expired on table Op. death
EVAR with an Excluder bifurcated graft Died @ 1.5 mos
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interposition grafting and ligation of a bleeding lumbar
artery. He was discharged to a nursing home and died 4
months later. The last patient (patient #16) underwent
endovascular left iliac limb extension and coil embolization
of the distal landing zone when he first presented with an
rAAA.He was discharged to home the next day. Three days
later, he presented to the emergency department with
another episode of severe abdominal pain. He was explored
for persistent bleeding and found to have an rAAA with
fresh thrombus in the retroperitoneum. The aneurysm sac
was opened and a type II endoleak from a lumbar artery was
noted; no evidence of a type I endoleak was present. The
artery was ligated and the sac closed without removal of the
endograft. The patient did well and was discharged to
home 13 days later only to return 5 days afterward with yet
another rupture. The etiology was unclear, but he was
noted to have diffuse bleeding through the fabric of an
Ancure device. The graft was explanted except for the
segments at the proximal and distal sealing zones and
replaced with a surgical graft. He developed other compli-
cations and died in the hospital.
The remaining 15 patients underwent a single thera-
peutic intervention. Open conversion was performed in 7
patients (complete explantation in 2 patients and partial in
5) with a surgical graft placement, whereas endovascular
intervention was performed/attempted in 10 patients
(proximal aortic extension in 3 patients, iliac extension in 5,
EVARwith a bifurcated endograft in 1, and a failed attempt
in 1 patient who died on the operating table).
Rupture without a previous EVAR (group 2). Of
233 patients in group 2, 218 patients underwent open
repairs, whereas the remaining 15 patients were treated by
EVAR. Overall, the in-hospital mortality rate was 36.9%.
Patients treated with EVAR seemed to have a slightly lower
mortality rate, 20.0%, than those who underwent open
Fig. Kaplan–Meier estimate of probability of survival in patients
who presented with ruptured abdominal aortic aneurysm (rAAA)
with and without antecedent endovascular aneurysm repair
(EVAR).repair, 38.1% (P  .27).Comparison of group 1 and 2. No significant differ-
ences in perioperative complication rates (66.7% vs 56.7%;
P .47) and operativemortality rates (38.9% vs 36.9%; P
.99) were noted between groups 1 and 2, respectively. Only
intraoperative blood product requirements were signifi-
cantly lower in group 1 compared to group 2 (Table I).
The probability of survival at 1 year was also similar
between groups, 27.8% (group 1) vs 48.2% (group 2; P 
.15; Fig). The multivariate analysis of operative mortality
with the multiple logistic regression model revealed that
advanced age and preoperative CPR were independent
predictors of death (P  .001).
DISCUSSION
This study represents the largest single-center experi-
ence of post-EVAR rAAA and shows that the operative
mortality rate for rAAA with antecedent EVAR is not
necessarily lower than that of de novo rAAA. Most patients
do not have a known endoleak or sac enlargement, render-
ing prediction of late rupture after EVAR difficult. Rupture
remains a potential, albeit rare, catastrophic event even in
patients with sac shrinkage and no endoleaks.
The reported operative mortality rates for post-EVAR
rAAA range widely from 16% to 67%.5,9-11,13-15May et al13
reported a significantly reduced mortality rate of 17% with
open repair of post-EVAR rAAA compared with 54% in
patients with de novo rAAA, and attributed its survival
benefit to the reduced blood loss and relative hemody-
namic stability. Several authors have postulated that an
existing stent graft improves the chance of survival by
providing hemodynamic stability.8,9,13 Coppi et al,9 in
their comparative analysis of 14 post-EVAR rAAA and 155
de novo rAAA, noted less frequent hemodynamic instabil-
ity (the only predictor of death identified in their series) in
patients with antecedent EVAR, but similar overall 30-day
mortality rates between the two groups (28.5% vs 38.7%,
respectively). Therapeutic modalities (open vs endovascu-
lar) did not have any impact on death rates between the two
groups either. Nonetheless, they supported the theoretical
survival advantage in the presence of an endograft. How-
ever, our experience does not support this assumption and
is more in line with a worldwide literature review recently
published by Schlösser et al.5 In a compilation of 270 late
AAA ruptures after EVAR, they reported a 43% (69 of 164)
operative mortality rate. Fransen et al10 also reported a 62%
operative mortality rate in a survey of 34 rAAAs after EVAR
from 4291 patients in the EUROSTAR registry. In the
present series, even the incidence of hemodynamic instabil-
ity did not differ between the two groups, although blood
product transfusion requirements were significantly lower
in patients with rAAAs after EVAR. The nearly identical
operative mortality rates between the two groups suggest
that the late ruptures after EVAR is as lethal as primary
rAAA.
Predictors of late AAA rupture after EVAR in the
literature have been found to include: large initial AAA
diameter,7,16-18 type I and III endoleaks,6,7,13,19-23 graft
migration,6,10,24 sac growth,7 and poor compliance with
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prit for late ruptures.5,9,10 In the present study, all post-
EVAR ruptures had an endoleak, but unfortunately, most
of them were not there at last follow-up. Timely detection
and treatment of type I or type III endoleaks and type II
endoleaks associated with sac growth should be a standard
practice. Type II endoleak is not necessarily a benign find-
ing,20 as it may develop and resolve spontaneously. In the
AneuRx trial, 5 of 7 patients with post-EVAR ruptures
showed no evidence of endoleak at last follow-up before
ruptures.18 Similarly, 77% of our patients showed no evi-
dence of endoleak at last follow-up in this study. It should
be noted, however, that follow-up imaging was available
for review in only 13 of 18 patients (72%) in the present
study, although 9 of them were within 12 months of
rupture. The majority of endoleaks found at the time of
rAAA were new. Others have also noted that up to 40%
of patients had no abnormalities detected at last follow-up
before rupture.5,10 The absence of endoleak during fol-
low-up does not mean that all is well.
Another parameter that is used and accepted as a sur-
rogate marker for a successful EVAR is AAA sac shrinkage.
Its value as a reliable sign of long-term success is debatable.
Shrinking AAA sac may re-expand over time.26 Reports
from the EUROSTAR registry and literature review indi-
cate that about 60% of patients showed either shrinking or
unchanged sac size at last follow-up.5,10 The findings in the
present study are in agreement with these reports; of 13
patients in whom size comparison was possible, only 3
patients had shown sac growth at last follow-up before
rupture. A shrinking or stable aneurysm sac size does not
necessarily reflect cure of the aneurysm and should not
result in a cessation of follow-up.9,25
Although sac size change and endoleak were not uni-
formly present in patients who ultimately rupture after EVAR,
a large initial size of the AAA treated is fairly prevalent among
these patients. Not only is it the primary determinant of the
risk of primary aneurysm rupture, but also seems tobe a strong
predictor of comorbidities,7,18 increased operative risk,7,27,28
and post-EVAR outcome.5,7,9,13,15,18 After EVAR, large
AAA is associated with late ruptures, type I endoleak, and
aneurysm-related death. Zarins et al,18 in a review of 923
patients treated with AneuRx stent grafts, showed that large
preoperative AAAs (6.0 cm) was the only independent
predictor of the aneurysm-specific endpoint of rupture, AAA-
related death, and conversion; the probability of freedom
from rupture at 5 years was 100% for AAAs 5 cm, 97% for
AAAs between 5 and 6 cm, and 93% for AAAs6 cm. Large
AAAwas also more likely to enlarge post-EVAR.18 Peppelen-
bosch et al,7 in a survey of data from 4392 patients in the
EUROSTAR registry, showed that the ratio of aneurysm-
related tounrelateddeathwas about 50% in patientswith large
(6.5 cm) preoperative AAA diameter as compared with 28%
and 23% in the smaller aneurysm groups. The mean preoper-
ative AAA size of those that ruptured after EVAR is 6.5 cm in
the Lifeline Registry and AneuRx study, whereas the mean
diameterofaneurysmstreatedwas5.6and5.7cm,respectively.18In the present study, the mean AAA size that ruptured after
EVAR was 6.4 cm, resonating the findings of others.7,10,13
Continued follow-up after EVAR is critical regardless
of the apparent success of the operation. As can be seen
from this series, the events and changes that lead to rupture
can be catastrophic and happen rapidly between follow-up
periods, and there were no tell tale signs that could portend
a future rupture. As such, it is not easy to provide a
recommendation regarding a follow-up protocol. In fact,
surveillance protocol after EVAR is evolving. The optimal
schedule that mayminimize rupture is not well defined, and
unfortunately, this report indicates that rupture can happen
even after a recent normal follow-up scan. At present, our
protocol includes a baseline CT scan at 1 month. If there is
no evidence of endoleak or device-related abnormalities, a
follow-up CT scan is obtained at 1 year. A stable or shrink-
ing aneurysm then usually prompts a switch to Duplex scan
as the modality of follow-up.
There are several limitations of this study including the
limitations of retrospective data collection, incomplete follow-
up, heterogeneity of pathophysiology, and treatment mo-
dalities in a small sample size of post-EVAR ruptures, which
limited statistical analysis. Many devices represented in this
series are either no longer available or in diminishing use.
The findings may not be applicable to newer generation
devices as technology continues to improve.
CONCLUSIONS
Ruptured AAAs with antecedent EVAR are as lethal as
de novo types. The endograft does not seem to provide any
survival benefits when the aneurysm ruptures. Prediction of
patients at risk for post-EVAR rupture is difficult, as it is
often a new catastrophic failure that may occur despite a
previous appearance of a successful exclusion of the sac.
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